Agenda

• Prevention Keynote: HIV Vaccine Development: How will we translate scientific opportunity into public health impact?
• Human Monoclonal Antibodies for Pre-Exposure Prophylaxis (PrEP) of HIV-1 Infection
• Progress in Advancing Vaccine Concepts to P5 Efficacy Trials
• Defining Correlates of Protection against HIV/SIV
• Ad26 Based Vaccines for HIV and Beyond
• Building on Prevention: How prophylactic vaccine trials inform HIV cure
• Targeting HIV Where it Hurts
• Treatment Keynote: Barriers to a Cure and Therapy: What will a vaccine need to do to be a success?